about
Loss of 5α-reductase type 1 accelerates the development of hepatic steatosis but protects against hepatocellular carcinoma in male mice.5α-Reductase Type 2 Regulates Glucocorticoid Action and Metabolic Phenotype in Human Hepatocytes.Dual-5α-Reductase Inhibition Promotes Hepatic Lipid Accumulation in ManOptimizing human hepatocyte models for metabolic phenotype and function: effects of treatment with dimethyl sulfoxide (DMSO).Development of hepatocellular carcinoma in a murine model of nonalcoholic steatohepatitis induced by use of a high-fat/fructose diet and sedentary lifestyle.Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal Hyperplasia.Glucocorticoids regulate AKR1D1 activity in human liver in vitro and in vivoAKR1D1 regulates glucocorticoid availability and glucocorticoid receptor activation in human hepatoma cellsAKR1D1 is a novel regulator of metabolic phenotype in human hepatocytes and is dysregulated in non-alcoholic fatty liver disease
P50
Q34316501-80DBE64F-4BB1-4078-8746-6EC107A7A3AFQ35878846-8560DA66-B90E-4B97-9215-D05C32FBCFFDQ36431676-7F0D3C97-8D5E-48B8-9807-0460B37D2A49Q38734208-910FD0E5-07ED-4468-B3E2-5109987ACC8FQ39102930-1A5A318E-AB24-4535-9F42-FA06978A6394Q53746019-8781DAA6-7D18-48B2-B3FD-AEB52B86608CQ89918517-34D27ABB-9927-431F-B671-3D8CD52FAC71Q91623812-D3C3E43A-5A49-422F-883D-A895E26599B2Q92076849-C8632E24-E858-4E2E-8394-B4FE09A1FF5A
P50
description
researcher, ORCID id # 0000-0002-8789-8436
@en
wetenschapper
@nl
name
Nikolaos Nikolaou
@ast
Nikolaos Nikolaou
@en
Nikolaos Nikolaou
@es
Nikolaos Nikolaou
@nl
type
label
Nikolaos Nikolaou
@ast
Nikolaos Nikolaou
@en
Nikolaos Nikolaou
@es
Nikolaos Nikolaou
@nl
prefLabel
Nikolaos Nikolaou
@ast
Nikolaos Nikolaou
@en
Nikolaos Nikolaou
@es
Nikolaos Nikolaou
@nl
P106
P1153
55938267000
P31
P496
0000-0002-8789-8436